These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9342259

  • 1. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994.
    Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, Eklund I, Engström A, Julander I, Käll K, Martin C, Stendahl P, Struve J, Sönnerborg A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug 15; 15(5):381-6. PubMed ID: 9342259
    [Abstract] [Full Text] [Related]

  • 2. HTLV-II among injecting drug users in Stockholm.
    Krook A, Blomberg J.
    Scand J Infect Dis; 1994 Aug 15; 26(2):129-32. PubMed ID: 8036466
    [Abstract] [Full Text] [Related]

  • 3. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
    de Araujo AC, Casseb JS, Neitzert E, de Souza ML, Mammano F, Del Mistro A, De Rossi A, Chieco-Bianchi L.
    Eur J Epidemiol; 1994 Apr 15; 10(2):165-71. PubMed ID: 7813694
    [Abstract] [Full Text] [Related]

  • 4. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jiménez V, Silva T, Project Itínere Working Group.
    J Clin Virol; 2006 Mar 15; 35(3):244-9. PubMed ID: 16143565
    [Abstract] [Full Text] [Related]

  • 5. HTLV infections among Swedish intravenous drug users in 1992.
    Andersson S, Krook A, Käll K, Julander I, Thorstensson R, Biberfeld G.
    Scand J Infect Dis; 1995 Mar 15; 27(6):547-50. PubMed ID: 8685631
    [Abstract] [Full Text] [Related]

  • 6. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
    Feigal E, Murphy E, Vranizan K, Bacchetti P, Chaisson R, Drummond JE, Blattner W, McGrath M, Greenspan J, Moss A.
    J Infect Dis; 1991 Jul 15; 164(1):36-42. PubMed ID: 2056217
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
    Giuliani M, Rezza G, Lepri AC, Di Carlo A, Maini A, Crescimbeni E, Palamara G, Prignano G, Caprilli F.
    Sex Transm Dis; 2000 Feb 15; 27(2):87-92. PubMed ID: 10676975
    [Abstract] [Full Text] [Related]

  • 8. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF, Hartel D, Lairmore M, Horsburgh CR, Schoenbaum EE, Roberts B, Hartley TM, Friedland G.
    J Infect Dis; 1991 Feb 15; 163(2):252-6. PubMed ID: 1988509
    [Abstract] [Full Text] [Related]

  • 9. HTLV-I and -II in intravenous drug users from Sweden and Denmark.
    Blomberg J, Moestrup T, Frimand J, Hansson BG, Krogsgaard K, Grillner L, Nordenfelt E.
    Scand J Infect Dis; 1994 Feb 15; 26(1):23-6. PubMed ID: 8191236
    [Abstract] [Full Text] [Related]

  • 10. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB, Jain S, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV, Flynn N.
    West J Med; 1992 Jan 15; 156(1):30-5. PubMed ID: 1310362
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
    Guerena-Burgueno F, Benenson AS, Sepulveda-Amor J, Ascher MS, Vugia DJ, Gallo D.
    Am J Trop Med Hyg; 1992 Aug 15; 47(2):127-32. PubMed ID: 1503181
    [Abstract] [Full Text] [Related]

  • 12. Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II.
    Guimarães ML, Bastos FI, Telles PR, Galvão-Castro B, Diaz RS, Bongertz V, Morgado MG.
    J Clin Virol; 2001 May 15; 21(2):143-51. PubMed ID: 11378495
    [Abstract] [Full Text] [Related]

  • 13. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA, Al EJ, Huisman JG, Goudsmit J, Coutinho RA.
    J Med Virol; 1991 Jun 15; 34(2):100-3. PubMed ID: 1890409
    [Abstract] [Full Text] [Related]

  • 14. Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil.
    Caterino-de-Araujo A, Sacchi CT, Gonçalves MG, Campos KR, Magri MC, Alencar WK, Group of Surveillance and Diagnosis of HTLV of Sa˜o Paulo (GSuDiHTLV-SP).
    AIDS Res Hum Retroviruses; 2015 May 15; 31(5):543-9. PubMed ID: 25464979
    [Abstract] [Full Text] [Related]

  • 15. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE, Hershow R, Kalish LA, Hardy WD, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 15; 19(5):513-8. PubMed ID: 9859966
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ, Cannon RO, Atkinson WL, Lutz B, Hook EW, Blattner WA, Quinn TC.
    J Infect Dis; 1992 May 15; 165(5):920-4. PubMed ID: 1569344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.